Home Newsfeeds Mizuho Initiates Coverage On Harmony Biosciences with Buy Rating, Announces Price Target of $64

Mizuho Initiates Coverage On Harmony Biosciences with Buy Rating, Announces Price Target of $64

Mizuho analyst Graig Suvannavejh initiates coverage on Harmony Biosciences (NASDAQ:HRMY) with a Buy rating and announces Price Target of $64.

July 7, 2022

1 minute read

Mizuho analyst Graig Suvannavejh initiates coverage on Harmony Biosciences (NASDAQ:HRMY) with a Buy rating and announces Price Target of $64.

Stifel Initiates Coverage On NVIDIA with Hold Rating, Announces Price Target of $165

September 8, 4:40 AM

Stifel analyst Ruben Roy initiates coverage on NVIDIA (NASDAQ:NVDA) with a Hold rating and announces Price Target of $165.

November 8, 3:36 PM

- Reuters

June 17, 9:07 AM

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. When insiders purchase shares,…

October 3, 9:08 AM

Vantiva SA (OTC: TCLRY) has entered into a call option agreement to acquire CommScope Holding Company, Inc.'s (NASDAQ: COMM)